albuminuria in relation to the single and combined effects of systolic and diastolic blood pressure...
TRANSCRIPT
Correspondence: Ji-Guang Wang, The Shanghai Institute of Hypertension, Ruijin 2nd Road 197, Shanghai 200025, China. Tel: � 86-21-64370045 ext 610911. Fax: � 86-21-64662193. E-mail: [email protected]
(Received 6 June 2012 ; accepted 23 October 2012 )
ORIGINAL ARTICLE
Albuminuria in relation to the single and combined effects of systolic and diastolic blood pressure in Chinese
CHANG-SHENG SHENG , MING LIU , JUN ZOU , QI-FANG HUANG , YAN LI & JI-GUANG WANG
Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Abstract We investigated the single and combined effects of systolic (SBP) and diastolic blood pressure (DBP) on albuminuria in Chinese. We measured blood pressure (BP), anthropometry and urinary excretions of albumin and creatinine, and defi ned albuminuria as a urinary albumin-to-creatinine ratio of at least 17 and 25 mg/g in men and women, respectively. The 1068 participants (mean age 56.3 years) included 407 (38.5%) men and 410 (38.4%) hypertensive patients. A J-shaped relation-ship between the risk of albuminuria and BP was observed for both SBP (mean � SD, 126.1 � 18.9 mmHg) and DBP (77.1 � 9.4 mmHg) with nadir levels of 110 mmHg and 70 mmHg, respectively. The risk of albuminuria was signifi cantly ( p � 0.01) associated with DBP in the subjects with a SBP of at least 130 mmHg and with SBP in subjects with a DBP of at least 80 mmHg, and inversely and signifi cantly ( p � 0.04) associated with SBP in subjects with a DBP below 70 mmHg. In conclusion, as far as albuminuria is concerned, there is indeed a J-shaped phenomenon. However, it has a nadir level far below the currently recommended target BP of 140/90 or 130/80 mmHg.
Key Words: Albuminuria , blood pressure , J-curve
Introduction
With the increasing longevity and obesity in most countries over the world, the prevalence of hyperten-sion increases rapidly. On the other hand, the control rate of hypertension remains low, particularly in China. According to the 2002 National Nutrition and Health Survey, the prevalence of hypertension was 18.8%, with approximately 160 million people with a systolic/diastolic blood pressure (SBP/DBP) of at least 140/90 mmHg, and the control rate was only 6.2% (1). The high prevalence and low control rate of hypertension are the major contributing factors of the fast increasing incidence rate of stroke and coronary heart disease in the most populous country over the world.
By lowering blood pressure (BP), antihyperten-sive treatment may effectively prevent complications of hypertension such as stroke, coronary heart dis-ease, congestive heart failure and renal dysfunction
(2,3). In spite of the overwhelming evidence of the benefi t of antihypertensive therapy, the J-curve phenomenon has been a major concern and hot topic and is recently revived in a high profi le, because several trials that included normotensive subjects (4 – 7) and/or tested intensive BP lowering (8,9) did not show overall benefi cial effects. The optimal BP level might be personalized, depending on the perfused organ, the function and structure of the vascular system, and probably also the combined effects of the peak systolic (SBP) and trough diastolic (DBP) level of BP within a cardiac cycle.
Albuminuria is an early marker of vascular and renal damage, and predicts cardiovascular events and mortality (10 – 12). In the present study, we investigated the single and combined effects of SBP and DBP on albuminuria in a Chinese population sample, with the focus on the J-curve phenomenon.
Blood Pressure, 2013; 22: 158–164
ISSN 0803-7051 print/ISSN 1651-1999 online © 2013 Scandinavian Foundation for Cardiovascular ResearchDOI: 10.3109/08037051.2012.748998
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
Blood pressure and albuminuria 159
Methods
Study population
The present cross-sectional analysis was based on the recent follow-up data of an ongoing longitudinal population study on multiple cardiovascular risk fac-tors in Shanghai, China (13). The Ethics Committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine approved the study protocol. All subjects gave written informed consent. The study subjects were recruited from a newly estab-lished residential area in the suburb of Shanghai, 30 kilometers from the city centre. Most residents were immigrants from the nearby villages since 2003, and previously doing farming or other agricultural work. In the period from 2004 to 2006, we invited all residents at least 12 years of age to take part. All residents were potentially eligible for inclusion into our study, as long as they could walk to the local examination centre on their own and had no clinically manifested disease. Of the 2275 invited, 1700 (74.7%) participated in the study.
At the time of the follow-up study in 2009, 1630 of the 1700 subjects were still alive, 1192 (73.1%) participated in the follow-up examinations. We excluded 124 subjects, because they did not have blood ( n � 22) or spot urine sampling ( n � 58) or anthropometric measurements ( n � 18), or because they were younger than 30 years of age ( n � 26). Thus, the total number of subjects included in the present analysis was 1068.
Field work
One experienced physician measured each partici-pant ’ s BP fi ve times consecutively by mercury sphyg-momanometry, after the subjects had rested for at least 5 min in the sitting position. These fi ve BP readings were averaged for analysis. The same observer also administered a standardized question-naire to collect information on medical history, smoking habit, alcohol intake and the use of medi-cations. Hypertension was defi ned as a sitting BP of at least 140 mmHg SBP or 90 mmHg DBP, or as the use of antihypertensive drugs. A trained techni-cian performed anthropometric measurements.
Laboratory work and defi nitions of disease conditions
Venous blood samples were drawn after overnight fasting for the measurement of plasma glucose concentration and for measurements of serum con-centrations of uric acid and creatinine. Diabetes mellitus was defi ned as a plasma glucose of at least 7.0 mmol/l fasting or 11.1 mmol/l at any time, or as the use of antidiabetic agents (14). Estimated glomerular fi ltration rate (eGFR) was calculated according to the Cockcroft – Gault formula (15).
Body surface area was calculated using the DuBois formula (16). Renal dysfunction was defi ned as an eGFR lower than 60 ml/min/1.73 m 2 . Fresh spot urine samples were collected for the measurement of urinary albumin and creatinine using immuno-turbidimetry and enzymatic methods, respectively. Urinary albumin excretion was expressed as the ratio of albumin-to-creatinine ratio (mg/g).
We defi ned microalbuminuria, according to a sex-specifi c criterion, as a urinary albumin-to-creatinine ratio in the range from 17 to 299 mg/g in men and from 25 to 299 mg/g in women (17,18), and defi ned macroalbuminuria as a urinary albumin-to-creatinine ratio more than 300 mg/g in men as well as women. Albuminuria included microalbu-minuria and macroalbuminuria.
Statistical analysis
For database management and statistical analysis, we used SAS software (version 9.13, SAS Institute, Cary, NC, USA). Means and proportions were compared with the standard normal z -test and Fisher ’ s exact test, respectively. We performed mul-tiple logistic regression analyses to study the associa-tion between albuminuria and BP, while controlling for covariates including sex, age, body mass index, current smoking, alcohol intake, use of antihyper-tensive drugs and diabetes mellitus. We considered individuals with SBP of 110 – 119 mmHg or DBP of 70 – 74 mmHg the reference group. Dummy vari-ables were used to compute odds ratios (95% confi -dence intervals) for each subgroup against the reference group. For the analysis on the joint effect of SBP and DBP, we fi rst subdivided the study sub-jects into three subgroups according to one com-ponent of BP and then studied the association of another component with the risk of albuminuria.
Results
The 1068 participants included 407 (38.1%) men, 66 (6.2%) diabetic patients and 410 (38.4%) hyper-tensive patients, of whom 331 (31.0%) took antihy-pertensive drugs. Men and women had similar SBP ( � SD; 125.1 � 18.7 mmHg), pulse rate (68.5 � 8.4 beats/min), and fasting plasma glucose (4.55 � 1.34 mmol/l, Table I). However, men, compared with women, were slightly older ( � 1.7 years, p � 0.03), had a signifi cantly ( p � 0.05) greater body mass index ( � 0.4 kg/m 2 ), and higher DBP ( � 3.2 mmHg), and reported higher ( p � 0.0001) proportions of current smoking (47.8% vs 0.5%) and alcohol intake (35.4% vs 1.2%).
Men and women had similar prevalence of albu-minuria (7.8%), and mild renal dysfunction (5.4%). The prevalence of albuminuria increased with SBP and DBP in men as well as women (Figure 1).
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
160 C.-S. Sheng et al.
However, we noticed a J-shape relationship for both BP components with a nadir level at 110 – 119 mmHg SBP and 70 – 74 mmHg DBP (Table II). After adjustment for sex, age, body mass index, current smoking, alcohol intake, use of antihypertensive drugs and diabetes mellitus, and additional mutual adjustment for the BP components, the J-shape rela-tionship remained, particularly with DBP (Table II). Indeed, the smallest odds ratio was observed at 110 – 119 mmHg SBP and 70 – 74 mmHg DBP.
In further analysis, we studied the combined effects of SBP and DBPs on albuminuria. After subdivision of all participants into three subgroups according to SBP ( � 120, 120 – 129 and � 130 mmHg) and DBP ( � 70, 70 – 79 and � 80 mmHg) BPs, we studied the risk of albuminuria in relation to the
tertile distributions of DBP and SBPs, respectively. Both before (Figure 2) and after (Table III) adjust-ment for sex, age, body mass index, current smoking, alcohol intake, use of antihypertensive drugs and diabetes mellitus, the risk of albuminuria was posi-tively and signifi cantly ( p � 0.01) associated with DBP in the subjects with a SBP of at least 130 mmHg and with SBP in subjects with a DBP of at least 80 mmHg, and inversely and signifi cantly ( p � 0.04) associated with SBP in subjects with a DBP below 70 mmHg.
Discussion
Our fi nding, obtained in a general population with relatively low levels of cardiovascular risk, showed a
Figure 1. Prevalence of albuminuria by sex and by systolic (left panel) and diastolic (right panel) blood pressure. Closed and open circles represent men and women, respectively. The number of subjects per group in men and women is given.
Table I. Characteristics of the study population.
Characteristic Men ( n � 407) Women ( n � 661) p -value
Age, years 57.4 � 12.2 55.7 � 12.2 0.03Body mass index, kg/m 2 24.3 � 3.4 23.9 � 3.2 0.03Blood pressure, mmHg
SystolicDiastolic
126.3 � 17.6 125.9 � 19.5 0.6979.0 � 9.6 75.8 � 9.1 � 0.0001
Pulse rate, beats/min 68.1 � 8.9 68.7 � 8.0 0.24Taking antihypertensive drugs, n (%) 139 (33.8) 192 (28.8) 0.11Hypertension, n (%) a 179 (43.6) 231 (34.7) 0.01Diabetes mellitus, n (%) a 28 (6.8) 38 (5.7) 0.50Plasma fasting glucose, mmol/l 4.52 � 1.56 4.63 � 1.31 0.21Serum creatinine, μ mol/l 70.0 � 12.5 54.3 � 17.9 � 0.0001Serum uric acid, μ mol/l 363.8 � 85.5 291.9 � 83.0 � 0.0001Microalbuminuria, n (%) a 28 (6.9) 40 (6.1) 0.63Macroalbuminuria, n (%) a 3 (0.7) 12 (1.8) 0.14Renal dysfunction a 25 (6.1) 33 (5.0) 0.43
Values are mean � SD, or number of subjects (%). a For defi nitions of hypertension, diabetes mellitus, microalbuminuria, macroalbuminuria and renal dysfunction, see Methods.
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
Blood pressure and albuminuria 161
J-shaped relationship between BP and target organ damage, such as, for instance, albuminuria. However, this phenomenon became apparent only if both SBP and DBPs were at low levels. One of the main clinical implications of our fi nding therefore is that SBP and DBPs that exceed the current threshold for the diagnosis of hypertension either alone or in combination confer cardiovascular risk. Of course, too low BP might also confer risks instead of benefi ts.
We studied single as well as combined effects of SBP and DBP, and found that the coexistence of too low levels in both BP components is the driving
force of the J-shaped relationship. Previous studies often studied single effects of SBP or DBP. In the post hoc analyses of the INVEST (the International Verapamil SR-Trandolapril Study) (19), TNT (the Treating to New Targets trial) (20) and ONTARGET (the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study) trials (21), the relationship between BP and cardiovascular events was analyzed for SBP and DBP separately, and concluded that low DBP was the major cause of the J-shaped relationship. Mainly based on these fi ndings, the scientifi c statement on antihyperten-sive therapy in patients with coronary artery disease
Table II. Albuminuria in relation to systolic and diastolic blood pressures.
Number of participants
Number of patients with albuminuria (prevalence, %)
Odds ratio (95% CI) a p -value
Systolic blood pressure (mmHg) � 110 204 6 (2.9) 1.36 (0.45 – 4.16) 0.59110 – 119 234 9 (3.8) 1.0 b – 120 – 129 228 11 (4.8) 1.06 (0.41 – 2.76) 0.91130 – 139 172 15 (8.7) 1.53 (0.58 – 4.04) 0.39 � 140 230 42 (18.3) 3.01 (1.12 – 8.06) 0.03
Diastolic blood pressure (mmHg) � 70 271 11 (4.1) 1.66 (0.55 – 5.06) 0.3770 – 74 200 5 (2.5) 1.0 b – 75 – 79 200 11 (5.5) 2.05 (0.70 – 6.06) 0.1980 – 84 182 20 (11.0) 3.33 (1.18 – 9.38) 0.03 � 85 215 36 (16.7) 4.68 (1.62 – 13.52) 0.004
a Odds ratios (95% confi dence interval [CI]) were calculated for each subgroup against the risk of the reference group in a single model, adjusted for sex, age, body mass index, current smoking, alcohol intake, use of antihypertensive drugs and diabetes mellitus, and mutually adjusted for diastolic or systolic blood pressure. b Reference group.
Figure 2. Prevalence of albuminuria by systolic and diastolic blood pressures. Values are prevalence of albuminuria in each tertile of systolic (right panel) and diastolic blood pressures (left panel) after subdivision by diastolic and systolic blood pressures, respectively. Tertiles 1, 2 and 3 are shown by open and closed circles, squares and diamonds, respectively.
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
162 C.-S. Sheng et al.
recommended that DBP should not be lowered to a level below 60 mmHg (22). This recommendation is important, but may also be confusing. Some patients may have a DBP below 60 mmHg before antihyper-tensive drug treatment is initiated. Some others may have such a low DBP before SBP is lowed to the goal. Physicians might hesitate to initiate or intensify antihypertensive therapy in these patients. It is therefore imperative to consider SBP and DBP together.
A major limitation of our study is its cross-sectional design, which does not allow us to draw any casual inference. However, because albuminuria is unlikely to cause low BP, it is plausible that albu-minuria in some persons is indeed the consequence of too low BP. Low BP in untreated subjects is different from that induced by antihypertensive drug treatment. In the latter case, BP may fl uctuate from high to low levels depending on the use of anti-hypertensive drugs. Recent studies have demon-strated that increased visit-to-visit BP variability may increase cardiovascular risk independent of BP level (23). Nonetheless, too low BP on both untreated and treated conditions would decrease perfusion of important organs, such as the brain, heart and kid-neys, and increase the risk of cardiovascular events.
Administration of drugs with BP lowering action in patients without high BP, regardless of high or low cardiovascular risk, should be closely monitored, and started from lower dosages.
In addition, although albuminuria is a predictor of cardiovascular events and mortality, our research cannot be directly compared with studies on hard outcomes. Albuminuria is a measure of long-term cardiovascular and renal risk of high BP or other risk factors, such as diabetes mellitus. However, cardiovascular events or mortality can be the consequence of long-term risk as well as of acute accidents, such as rupture of plaques, vasospasm, etc.
We only studied albuminuria, which is usually considered a chronic kidney disease. Our fi nding probably cannot be extrapolated to other target organs, such as the brain and heart. The J-curve phe-nomenon can be organ-specifi c. Indeed, in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) (8) and NAVIGATOR (the Nateglinide and Valsartan in Impaired Glucose Tolerance Out-comes Research) trials (7), a J-shaped relationship between intensive BP lowering and cardiovascular events was observed for coronary events but not for stroke, the risk of which was actually reduced in both trials. In contrast, in the ADVANCE (the Action in
Table III. Albuminuria in relation to the combined effects of systolic and diastolic blood pressures.
Number of participants
Number of patients with albuminuria
(prevalence, %)Odds ratio (95% CI) a P
Systolic blood pressure � 120 mmHgDBP tertile 1, � 68 mmHg 128 5 (3.9) 1.0 b – DBP tertile 2, 68 – 74 mmHg 149 6 (4.0) 1.89 (0.43 – 8.39) 0.40DBP tertile 3, � 74 mmHg 151 4 (2.6) 1.09 (0.20 – 5.93) 0.92
Systolic blood pressure, 120 – 129 mmHgDBP tertile 1, � 75 mmHg 76 1 (1.3) 1.0 b – DBP tertile 2, 75 – 82 mmHg 78 4 (5.1) 4.43 (0.44 – 44.77) 0.21DBP tertile 3, � 82 mmHg 74 6 (8.1) 8.35 (0.73 – 95.88) 0.09
Systolic blood pressure � 130 mmHgDBP tertile 1, � 80 mmHg 127 9 (7.1) 1.0 b – DBP tertile 2, 80 – 86 mmHg 132 20 (15.1) 2.33 (0.97 – 5.62) 0.06DBP tertile 3, � 86 mmHg 143 28 (19.6) 3.57 (1.33 – 9.59) 0.01
Diastolic blood pressure � 70 mmHgSBP tertile 1, � 105 mmHg 89 3 (3.3) 1.0 b – SBP tertile 2, 105 – 116 mmHg 92 5 (5.4) 0.46 (0.07 – 2.91) 0.41SBP tertile 3, � 116 mmHg 90 3 (3.3) 0.10 (0.01 – 0.96) 0.04
Diastolic blood pressure, 70 – 79 (mmHg)SBP tertile 1, � 114 mmHg 133 4 (3.0) 1.0 b – SBP tertile 2, 114 – 123 mmHg 117 3 (2.6) 0.61 (0.13 – 2.96) 0.54SBP tertile 3, � 123 mmHg 150 9 (6.0) 0.89 (0.19 – 4.12) 0.88
Diastolic blood pressure � 80 (mmHg)SBP tertile 1, � 130 mmHg 130 6 (4.6) 1.0 b – SBP tertile 2, 130 – 144 mmHg 134 9 (6.7) 2.52 (0.97 – 6.56) 0.06SBP tertile 3, � 144 mmHg 133 31 (23.3) 3.95 (1.34 – 11.69) 0.01
SBP, systolic blood pressure; DBP, diastolic blood pressure. a Odds ratios (95% confi dence interval [CI]) were calculated for each of the three tertile subgroups against the risk of the reference group in a single model, after subdivision of the study subjects into tertiles of SBP and DBP, respectively, and adjusted for sex, age, body mass index, current smoking, alcohol intake, use of antihypertensive drugs and diabetes mellitus. b Reference group.
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
Blood pressure and albuminuria 163
Diabetes and Vascular Disease:Preterax and Diamicron Modifi ed Release Controlled Evaluation) trial (24), intensive BP lowering signifi cantly reduced the inci-dence of coronary events and albuminuria, but did not infl uence the risk of stroke, despite 6/3 mmHg of SBP and DBP reductions, respectively. The dis-crepancy between these trials is not entirely under-stood, but clearly suggested the complexity of the J-curve issue.
The results of our study should be interpreted within the context of several other limitations. First, the sample size of our study was relatively small. For this reason and also because of the difference in the distributions of BP between the three subgroups in our analyses on the combined effects of SBP and DBPs, we had to subdivide our study subjects according to tertile distributions instead of absolute values of BP. Second, our study subjects were recruited from a single town in the suburb of Shanghai. Our study might be less representative of the Chinese population than multicentre studies, such as the 2002 National Nutrition and Health Survey (1) and the 2008 National Diabetes Survey (25), but might not necessarily be less appropriate for research such as the present analysis. Finally, the low SBP and DBPs could also be a consequence of left ventricular dysfunction. We excluded patients with overt heart failure according to the question-naire data on medical history and the use of drugs. However, we did not perform echocardiographic measurements, and therefore cannot entirely rule out the possibility that a small proportion of subjects with compensatory left ventricular dysfunction were included in the present analysis.
In conclusion, there is indeed a J-shaped relation-ship between BP and albuminuria. However, it has a nadir level far below the currently recommended target BP of 140/90 mmHg or 130/80 mmHg, and is apparent only if both SBP and DBPs are at low levels. Nonetheless, the J-curve issue is impor-tant, requires accurate measurement of BP, and should be investigated in future studies.
Acknowledgments
The authors gratefully acknowledge the voluntary participation of all study subjects and the technical assistance of the physicians and nurses of Zhaoxiang Community Health Centre (Qingpu District, Shanghai). The authors also appreciate the expert assistance of Jie Wang, and Wei-Zhong Zhang (The Shanghai Institute of Hypertension, Shanghai, China). The present study was fi nancially supported by grants from the National Natural Science Foundation of China (grants 30871360, 30871081, and 81170245), the Ministry of Science and Technology (2006BAI01A03 and a grant for China-European Union collaborations [1012]), and the Ministry of Education (NCET-09-0544), Beijing
China, the Shanghai Commissions of Science and Technology (grant 07JC14047, the “ Rising Star ” program 06QA14043, and 11QH1402000) and Education (grant 07ZZ32 and the “ Dawn ” project 08SG20), the Shanghai Bureau of Health (2009111 and XBR2011004), the Shanghai Shenkang Hospital Development Centre (SHDC12007318), Shanghai Jiaotong University School of Medicine (a grant of Distinguished Young Investigators to Yan Li), and the European Union (grants LSHM-CT-2006-037093 and HEALTH-F4-2007-201550).
Confl ict of interest: None.
References
1. Li LM , Rao KQ , Kong LZ , Yao CH , Xiang HD , Zhai FY , et al.; Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002 . Chin J Epidemiol 2005; 26 : 478 – 84 (in Chinese) .
2. Collins R , Peto R , MacMahon S , Hebert P , Fiebach NH , Eberlein KA , et al . Blood pressure, stroke, and coronary heart disease . Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990 ; 335 : 827 – 38 .
3. Staessen JA , Gasowski J , Wang JG , Thijs L , Den Hond E , Boissel JP , et al . Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials . Lancet 2000 ; 355 : 865 – 72 .
4. Telmisartan Randomised AssessmeNt Study in ACE iNtoler-ant subjects with cardiovascular Disease (TRANSCEND) Investigators ; Yusuf S , Teo K , Anderson C , Pogue J , Dyal L , Copland I , et al . Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet 2008 ; 372 : 1174 – 83 .
5. Massie BM , Carson PE , McMurray JJ , Komajda M , McKelvie R , Zile MR , et al.; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejec-tion fraction . N Engl J Med 2008 ; 359 : 2456 – 67 .
6. Yusuf S , Diener HC , Sacco RL , Cotton D , Ounpuu S , Lawton WA , et al.; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events . N Engl J Med 2008 ; 359 : 1225 – 37 .
7. NAVIGATOR Study Group ; McMurray JJ , Holman RR , Haffner SM , Bethel MA , Holzhauer B , Hua TA , et al . Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010 ; 362 : 1477 – 90 .
8. ACCORD Study Group ; Cushman WC , Evans GW , Byington RP , Goff DC Jr , Grimm RH Jr , Cutler JA , et al . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 ; 362 : 1575 – 85 .
9. Ogihara T , Saruta T , Rakugi H , Matsuoka H , Shimamoto K , Shimada K , et al.; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study . Hypertension 2010 ; 56 : 196 – 202 .
10. Arnl ö v J , Evans JC , Meigs JB , Wang TJ , Fox CS , Levy D , et al . Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study . Circulation 2005 ; 112 : 969 – 75 .
11. Blecker S , Matsushita K , K ö ttgen A , Loehr LR , Bertoni AG , Boulware LE , et al . High-normal albuminuria and risk of
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.
164 C.-S. Sheng et al.
heart failure in the community . Am J Kidney Dis 2011 ; 58 : 47 – 55 .
12. Warnock DG , Muntner P , McCullough PA , Zhang X , McClure LA , Zakai N ; REGARDS Investigators. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study . Am J Kidney Dis 2010 ; 56 : 861 – 71 .
13. Sheng CS , Hu BC , Fan WX , Zou J , Li Y , Wang JG . Micro-albuminuria in relation to the metabolic syndrome and its components in a Chinese population . Diabetol Metab Syndr 2011 ; 3 : 6 .
14. Alberti KG , Zimmet PZ . Defi nition, diagnosis and classifi -cation of diabetes mellitus and its complications. Part 1: Diagnosis and classifi cation of diabetes mellitus provisional report of a WHO consultation . Diabet Med 1998 ; 15 : 539 – 553 .
15. Cockcroft DW , Gault HM . Prediction of creatinine clearance from serum creatinine . Nephron 1976 ; 16 : 31 – 41 .
16. DuBois D , DuBois EF . A formula to estimate the approxi-mate surface area if height and weight are known . Ann Internal Med 1916 ; 17 : 863 – 71 .
17. Warram JH , Gearin G , Laffel L , Krolewski AS . Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defi ned by urinary albumin/creatinine ratio . J Am Soc Nephrol 1996 ; 7 : 930 – 37 .
18. Mattix HJ , Hsu CY , Shaykevich S , Curhan G . Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race . J Am Soc Nephrol 2002 ; 13 : 1034 – 39 .
19. Denardo SJ , Messerli FH , Gaxiola E , Aranda JM Jr , Cooper-Dehoff RM , Handberg EM , et al . Coronary revascu-larization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]) . Am J Cardiol 2010 ; 106 : 498 – 503 .
20. Bangalore S , Messerli FH , Wun CC , Zuckerman AL , DeMicco D , Kostis JB , et al.; Treating to New Targets
Steering Committee and Investigators. Treating to New Targets Steering Committee and Investigators. J-curve revis-ited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial . Eur Heart J 2010 ; 31 : 2897 – 908 .
21. Sleight P , Redon J , Verdecchia P , Mancia G , Gao P , Fagard R , et al.; ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study . J Hypertens 2009 ; 27 : 1360 – 9 .
22. Rosendorff C , Black HR , Cannon CP , Gersh BJ , Gore J , Izzo JL Jr , et al.; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: A scientifi c statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Preventi on . Circulation 2007 ; 115 : 2761 – 88 .
23. Rothwell PM , Howard SC , Dolan E , O’Brien E , Dobson JE , Dahl ö f B , et al . Prognostic signifi cance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension . Lancet 2010 ; 375 : 895 – 905 .
24. Patel A ; ADVANCE Collaborative Group ; MacMahon S , Chalmers J , Neal B , Woodward M , Billot L , Harrap S , et al. Effects of a fi xed combination of perindopril and inda-pamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007 ; 370 : 829 – 40 .
25. Yang W , Lu J , Weng J , Jia W , Ji L , Xiao J , et al.; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China . N Engl J Med 2010 ; 362 : 1090 – 101 .
Blo
od P
ress
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f W
ater
loo
on 1
1/04
/14
For
pers
onal
use
onl
y.